• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Abstract Aim The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …

Despite marked progress in the management of atrial fibrillation (AF), detecting AF remains
difficult and AF-related complications cause unacceptable morbidity and mortality even on …

Atrial fibrillation (AF) is the most common arrhythmia among patients with heart failure (HF),
and HF is the most common cause of death for patients presenting with clinical AF. AF is …

Background Atrioventricular nodal ablation (AVNA) combined with biventricular pacing
(BVP) improves outcomes in patients with persistent atrial fibrillation (AF), adequate rate …

Cardiac physiologic pacing (CPP), encompassing cardiac resynchronization therapy (CRT)
and conduction system pacing (CSP), has emerged as a pacing therapy strategy that may …

Aims The effect of atrial fibrillation catheter ablation on cardiovascular outcomes in heart
failure is an important outstanding research question. We undertook a meta-analysis of …

Background Single-center studies have shown feasibility of conduction system pacing (CSP)
via His-bundle pacing (HBP) or left bundle branch area pacing (LBBAP) in atrial fibrillation …

Background: Left bundle branch pacing (LBBP) has emerged as a promising pacing
modality to preserve physiological left ventricular activation; however, prospective data …